You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
迪安診斷(300244.SZ):擬119.64億韓元出售Biocore20.03%股份
格隆匯 07-01 18:44

格隆匯 7 月 1日丨迪安診斷(300244.SZ)公佈,為了提高資產流動性和使用效率,有效規避證券市場投資風險,公司擬將香港迪安持有的Biocore Co., Ltd.(“Biocore”)的138.3105萬股股份(佔Biocore股份總額的20.03%),以8650韓元/股的價格通過協議轉讓的方式出售給Invites Healthcare Co., Ltd.(“Invites Healthcare”);交易金額預計為約119.64億韓元(按照2020年6月30日的匯率,中國人民銀行中間價為1韓元對人民幣0.0059元,摺合人民幣約7058.68萬元)。此次交易後,公司不再持有Biocore公司的股權。

針對此次交易,董事會結合受讓方近期主要財務數據和資信情況等進行判斷,認為受讓方支付能力良好,故股權轉讓款項收回不存在相應風險。此次交易不會對公司的持續經營能力造成影響,不存在損害公司和中小股東權益的情況,符合公司長遠發展規劃,符合全體股東和公司利益。經測算,此次交易完成後預計為迪安診斷帶來約3600萬元人民幣的處置收益(最終以會計師審計為準),對公司2020年度或未來財務狀況和經營成果產生積極影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account